ATOSSA THERAPEUTICS INC (ATOS) Stock Balance Sheet
NASDAQ:ATOS - Nasdaq - US04962H5063 - Common Stock - Currency: USD
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 57.86M | 71.08M | 88.46M | 110.90M | 136.40M | |||
| Receivables | N/A | N/A | 0.00 | 700.00K | 1.10M | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 4.66M | 3.37M | 3.76M | 6.50M | 3.80M | |||
| Total Current Assets | 62.52M | 74.46M | 92.22M | 118.20M | 141.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | N/A | 0.00 | |||
| Investments And Advances | N/A | 0.00 | 1.71M | 4.70M | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 2.00M | 1.99M | 2.32M | 600.00K | 0.00 | |||
| Total Non-Current Assets | 2.00M | 1.99M | 4.03M | 5.30M | 100.00K | |||
| TOTAL ASSETS | 64.52M | 76.44M | 96.25M | 123.50M | 141.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.25M | 2.78M | 2.63M | 2.60M | 1.40M | |||
| Accounts Payable | 2.01M | 679.00K | 806.00K | 3.00M | 1.70M | |||
| Other Current Liabilities | 1.56M | 1.51M | 1.80M | 0.00 | 0.00 | |||
| Total Current Liabilities | 6.82M | 4.97M | 5.24M | 5.60M | 3.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 6.82M | 4.97M | 5.24M | 5.60M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -226.93M | -211.79M | -186.29M | -156.20M | -129.20M | |||
| Additional Paid In Capital | 262.62M | 261.26M | 255.99M | 250.80M | 244.00M | |||
| Common Shares | 23.49M | 23.49M | 22.79M | 23.40M | 23.40M | |||
| Treasury Stock | -1.48M | -1.48M | -1.48M | N/A | N/A | |||
| Shares Outstanding | 129.17M | 129.17M | 125.30M | 126.60M | 126.60M | |||
| Tangible Book Value per Share | 0.45 | 0.55 | 0.73 | 0.93 | 1.09 | |||
| Total Shareholders' Equity | 57.70M | 71.48M | 91.02M | 118.00M | 138.10M | |||
| TOTAL LIABILITIES AND EQUITY | 64.52M | 76.44M | 96.25M | 123.50M | 141.30M | |||
| Statistics | ||||||||
| Current Ratio | 9.17 | 14.99 | 17.61 | 21.11 | 45.55 | |||
| Return On Assets (ROA) | -44.51% | -33.36% | -31.27% | -21.83% | -14.59% | |||
| Return On Equity (ROE) | -49.78% | -35.68% | -33.06% | -22.85% | -14.92% | |||
All data in USD , ROIC based on taxRate of 0.21